Florence, South Carolina 2021-03-02 16:27:13 –
Washington(NewsNation Now) — President Biden has announced that the United States will vaccinate all adults by the end of May.
“About three weeks ago, we were able to say that we had a good supply of vaccines for adults by the end of July. We are pleased to announce today as a result of the step-up process we just ordered and outlined. By the end of May, the country will have enough vaccine for all adults in the United States. That’s an improvement, “Biden said.
Biden has called for an announcement that Merck and Co Inc will help rival Johnson & Johnson create a single-shot COVID-19 vaccine in partnership. This is an example of a “good corporate citizen”.
Biden also added that all teachers would like to see enough vaccine to receive the first dose of the vaccine by the end of March.
“As soon as we learned of the fact that Johnson and Johnson were lagging behind in the manufacturing process and efforts, we took steps to promote it and allow us to partner with one of the world’s largest manufacturers. “Psaki told the White House briefing.
Psaki said the US government would implement the Defense Production Act to equip Merck’s plants with the ability to produce J & J vaccines.
Biden announces partnership in ongoing speech on coronavirus A pandemic that claimed the lives of more than 510,000 people Nationwide.
The announcement comes when the White House is trying to speed up production Single vaccine.. Officials said J & J faced an unexpected production problem with the vaccine and produced only 3.9 million doses before obtaining an emergency use authorization on Saturday. According to the company, it is proceeding at a pace of 100 million doses by the end of June.
White House spokesman Jen Psaki also announced on Tuesday that the federal government has increased vaccine supplies to the state next week from the previous 14.5 million to 15.2 million. The state will also receive 2.8 million J & J shots this week.
Under that agreement, J & J was supposed to administer 12 million doses by the end of February, but when the vaccine was approved on Saturday, less than 4 million doses were ready for shipment.
We expect to receive an additional 16 million doses by the end of the month, well below our previous promise, but will not ship next week. The company said it could provide the full dose of 100 million doses agreed to be supplied by the initial interim deadline.
Richard Nettles, vice president of J & J, faced a question about the company’s late delivery, and last week told Capitol Hill lawmakers that the company faced a “significant challenge” due to its “very complex” manufacturing process. Said.
J & J’s vaccines are manufactured in factories operated by Emergent BioSolutions Inc and in facilities in the Netherlands and India.
There are two US factories operated by Catalent and Grand River Asceptic Manufacturing, where vaccines are completed and placed in vials. The company also has partners with fill-finishing capabilities in Spain, Italy, India and South Africa.
The collaboration between Merck and J & J took place in January after Merck abolished the development of its own COVID-19 vaccine candidate. The company said last month that it was in talks with governments and businesses about the possibility of supporting the production of a licensed COVID-19 vaccine.
The Washington Post reports that Merck will dedicate two US facilities to Johnson & Johnson’s vaccine.
“Merck adheres to our commitment to contributing to the global response to pandemics,” the company said.
Johnson & Johnson did not immediately respond to the request for comment.
McKesson Corporation, a US government COVID-19 vaccine distribution partner, began shipping Johnson & Johnson vaccines from its Kentucky factory to the state on Monday.
McKesson has four facilities specializing in the distribution of J & J vaccines.
So far, Johnson & Johnson’s shots The only single-dose coronavirus vaccine available in the United States It also makes storage and distribution much easier because it does not require the ultra-low temperature storage previously required for the Pfizer and Moderna double dose vaccines.
This vaccine is said to be suitable for elderly people at home, homeless people, and others who have difficulty booking a second dose.
The Associated Press and Reuters contributed to this report.Report by Manas Mishra of Reuters, Michael Ahman, with Nandita Bose AP Zeke Miller.
Biden: Enough COVID-19 vaccine doses for every adult by end of May Source link Biden: Enough COVID-19 vaccine doses for every adult by end of May